Trial Profile
An Open Label Study Regimen of Videx (2',3'-Dideoxyinosine, ddI) in Children With Acquired Immunodeficiency Syndrome (AIDS) Who Have Demonstrated Significant Deterioration or Intolerance to Zidovudine (Retrovir).
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 23 Jun 2011
Price :
$35
*
At a glance
- Drugs Didanosine (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 08 Jun 2009 New trial record.